These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 19504490)
1. How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials. Bump GM; Dandu M; Kaufman SR; Shojania KG; Flanders SA J Hosp Med; 2009 May; 4(5):289-97. PubMed ID: 19504490 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Wein L; Wein S; Haas SJ; Shaw J; Krum H Arch Intern Med; 2007 Jul; 167(14):1476-86. PubMed ID: 17646601 [TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients. Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080 [TBL] [Abstract][Full Text] [Related]
4. Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period. Bain E; Wilson A; Tooher R; Gates S; Davis LJ; Middleton P Cochrane Database Syst Rev; 2014 Feb; (2):CD001689. PubMed ID: 24519568 [TBL] [Abstract][Full Text] [Related]
5. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Kamphuisen PW; Agnelli G Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999 [TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161 [TBL] [Abstract][Full Text] [Related]
7. WITHDRAWN: Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Alikhan R; Cohen AT Cochrane Database Syst Rev; 2010 Feb; (2):CD003747. PubMed ID: 20166070 [TBL] [Abstract][Full Text] [Related]
8. Heparin for the prevention of venous thromboembolism in general medical patients (excluding stroke and myocardial infarction). Alikhan R; Cohen AT Cochrane Database Syst Rev; 2009 Jul; (3):CD003747. PubMed ID: 19588346 [TBL] [Abstract][Full Text] [Related]
9. Enoxaparin in the treatment of deep vein thrombosis with or without pulmonary embolism: an individual patient data meta-analysis. Mismetti P; Quenet S; Levine M; Merli G; Decousus H; Derobert E; Laporte S Chest; 2005 Oct; 128(4):2203-10. PubMed ID: 16236875 [TBL] [Abstract][Full Text] [Related]
10. Randomised controlled trial for efficacy of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in thrombo-prophylaxis. Ishi SV; Lakshmi M; Kakde ST; Sabnis KC; Jagannati M; Girish TS; Jeyaseelan L; Cherian AM J Assoc Physicians India; 2013 Dec; 61(12):882-6. PubMed ID: 24968543 [TBL] [Abstract][Full Text] [Related]
11. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer. Akl EA; Labedi N; Terrenato I; Barba M; Sperati F; Sempos EV; Muti P; Cook D; Schünemann H Cochrane Database Syst Rev; 2011 Nov; (11):CD009447. PubMed ID: 22071865 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis. Själander A; Jansson JH; Bergqvist D; Eriksson H; Carlberg B; Svensson P J Intern Med; 2008 Jan; 263(1):52-60. PubMed ID: 18088252 [TBL] [Abstract][Full Text] [Related]
13. [Evidence-based guidelines for prevention and therapy of venous thromboembolism]. Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Mismetti P; Laporte S; Darmon JY; Buchmüller A; Decousus H Br J Surg; 2001 Jul; 88(7):913-30. PubMed ID: 11442521 [TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline. Lederle FA; Zylla D; MacDonald R; Wilt TJ Ann Intern Med; 2011 Nov; 155(9):602-15. PubMed ID: 22041949 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of low molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery: a meta-analysis of randomised clinical trials. Palmer AJ; Koppenhagen K; Kirchhof B; Weber U; Bergemann R Haemostasis; 1997; 27(2):75-84. PubMed ID: 9212355 [TBL] [Abstract][Full Text] [Related]
17. Preventing venous thromboembolism in medical patients. Leizorovicz A; Mismetti P Circulation; 2004 Dec; 110(24 Suppl 1):IV13-9. PubMed ID: 15598642 [TBL] [Abstract][Full Text] [Related]
18. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis. Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389 [TBL] [Abstract][Full Text] [Related]
19. Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials. Mismetti P; Laporte-Simitsidis S; Tardy B; Cucherat M; Buchmüller A; Juillard-Delsart D; Decousus H Thromb Haemost; 2000 Jan; 83(1):14-9. PubMed ID: 10669147 [TBL] [Abstract][Full Text] [Related]